FDA works to re­duce dog test­ing in drug de­vel­op­ment

FDA re­searchers are work­ing to de­vel­op a new in­for­mat­ics mod­el to re­duce the re­liance on dogs to con­duct stud­ies in an­i­mal drug de­vel­op­ment.

The agency’s new study, which was pro­posed on Fri­day, is in­tend­ed to aid an­i­mal drug de­vel­op­ers in con­duct­ing cer­tain re­search with­out the need for prod­uct test­ing on dogs.

An­i­mal drug de­vel­op­ers would be able to use the new mod­el as a mech­a­nism for com­par­ing blood lev­els of cer­tain oral­ly-ad­min­is­tered ca­nine drugs to sup­port FDA ap­proval based on their ex­ist­ing re­search.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER